Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications
Effects of nebulized alpha-2 macroglobulin in horses with lower airway inflammation.
Journal: Journal of equine veterinary science
Published: December 23, 2025
Acalabrutinib in combination with rituximab and lenalidomide in patients with relapsed or refractory follicular lymphoma: Results of the phase 1b open-label study (ACE-LY-003).
Journal: British journal of haematology
Published: August 22, 2024
Acalabrutinib alone or in combination with rituximab for follicular lymphoma: An open-label study.
Journal: British journal of haematology
Published: May 23, 2024
Safety and efficacy of parsaclisib in combination with obinutuzumab and bendamustine in patients with relapsed or refractory follicular lymphoma (CITADEL-102): A phase 1 study.
Journal: Hematological oncology
Published: February 17, 2023
Zanubrutinib in patients with treatment-naïve or relapsed/refractory Waldenström macroglobulinemia: An expanded-access study of 50 patients in the United States.
Journal: EJHaem
Published: September 30, 2022
A phase 2, multicentre, open-label trial (ACE-LY-003) of acalabrutinib in patients with relapsed or refractory marginal zone lymphoma.
Journal: British journal of haematology
Published: April 22, 2022
The MAGNOLIA Trial: Zanubrutinib, a Next-Generation Bruton Tyrosine Kinase Inhibitor, Demonstrates Safety and Efficacy in Relapsed/Refractory Marginal Zone Lymphoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 01, 2021
Carfilzomib and dexamethasone induction with lenalidomide, clarithromycin and dexamethasone consolidation and lenalidomide maintenance for newly diagnosed multiple myeloma.
Journal: American journal of hematology
Published: May 10, 2021
Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial.
Journal: Blood cancer journal
Published: January 18, 2021
Last Updated: 09/26/2026